The EPIC-Norfolk Study

 

Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies.

Roviello G, Andre F, Venturini S, Pistilli B, Curigliano G, Cristofanilli M, Rosellini P, and Generali D

European journal of cancer (Oxford, England : 1990). Aug 2017

(DOI : 10.1016/j.ejca.2017.09.018)

---